2023, Venkatraman Radhakrishnan, Cancer Institute (WIA), Chennai, India, “REDUCING CHEMOTHERAPY DOSE INTENSITY BY 25% AND ADDING RITUXIMAB IMPROVES SURVIVAL IN PEDIATRIC MATURE B-CELL NON-HODGKIN’S LYMPHOMA IN LMIC SETTING”.

2024, Eyşan Hanzade Savaş, Koç University, Istanbul, Türkiye, Institut de Recerca Sant Joan de Déu, Barcelona, Spain “The Effect of Biofeedback-Based Virtual Reality Game on Pain, Fear, and Anxiety Levels During Port Catheter Needle Insertion in Pediatric Oncology Patients: A Randomized Controlled Study”.